HNL Lab Medicine Executive and Leadership Team

Matthew Sorrentino, the Chief Executive Officer at HNL Lab Medicine, directs the overarching strategic vision for the organization. Sorrentino architects long-term growth initiatives by expanding diagnostic service capabilities across Pennsylvania and New Jersey. By aligning laboratory output with the evolving needs of hospitals and physician offices, the Chief Executive Officer ensures consistent operational excellence. This leadership role involves managing complex stakeholder relationships and driving the adoption of advanced pathology technologies. Matthew Sorrentino monitors market trends to maintain a competitive edge in the medical diagnostics sector. Through rigorous oversight of clinical service delivery, the Chief Executive Officer secures the organization's reputation as a premier provider of laboratory testing. Strategic planning under Sorrentino focuses on scaling infrastructure to meet the demands of diverse industrial clients and long-term care facilities, ultimately fostering sustainable organizational health and high-quality patient outcomes throughout the regional healthcare landscape.

David Beckwith, the President & Chief Executive Officer at HNL Lab Medicine, governs the enterprise-wide execution of diagnostic service delivery. Beckwith drives the integration of clinical pathology workflows to enhance efficiency for healthcare providers. Overseeing the alignment of laboratory resources with regional medical demands, the President & Chief Executive Officer ensures that diagnostic results meet stringent quality standards. This role involves coordinating with the board to refine business models that support hospitals and physician offices. David Beckwith manages the expansion of service reach, ensuring that the laboratory maintains a robust presence across Pennsylvania and New Jersey. By optimizing internal processes, the President & Chief Executive Officer facilitates seamless communication between clinical teams and external partners. Beckwith prioritizes the development of scalable diagnostic solutions that address the complex needs of industrial clients, thereby strengthening the market position of the organization within the competitive health services sector.

Martin Till, the President & Chief Executive Officer at HNL Lab Medicine, leads the organizational transformation toward digital diagnostic integration. Till architects partnerships with healthcare systems to streamline the delivery of anatomic pathology results. By focusing on the modernization of laboratory infrastructure, the President & Chief Executive Officer improves turnaround times for critical patient testing. This leadership position requires constant evaluation of clinical service performance to ensure alignment with regional healthcare requirements. Martin Till manages the implementation of advanced diagnostic protocols that support physician offices and long-term care facilities. Through the optimization of service delivery models, the President & Chief Executive Officer drives operational efficiency across the entire network. Till fosters a culture of precision and reliability, ensuring that the laboratory remains a trusted partner for medical providers. This strategic focus on innovation allows the organization to adapt to the shifting landscape of medical diagnostics in Pennsylvania and New Jersey.

David Confalone, the Chief Financial Officer at HNL Lab Medicine, directs the financial strategy and fiscal health of the organization. Confalone architects budgeting processes that support the expansion of diagnostic services across the region. By overseeing revenue cycle management, the Chief Financial Officer ensures the financial sustainability of laboratory operations. This role involves analyzing cost structures to optimize the delivery of clinical and anatomic pathology services. David Confalone manages capital investments in new diagnostic technology to maintain a competitive edge in the market. Through rigorous financial reporting, the Chief Financial Officer provides the board with insights into the economic performance of the organization. Confalone coordinates with other C-suite leaders to align financial resources with strategic growth initiatives. By maintaining strong relationships with financial partners, the Chief Financial Officer secures the necessary funding to support the evolving needs of hospitals, physician offices, and industrial clients throughout Pennsylvania and New Jersey.

Warren Erdmann, the Chief Operating Officer at HNL Lab Medicine, manages the daily execution of laboratory operations and clinical workflows. Erdmann architects the logistics of specimen processing to ensure rapid and accurate diagnostic results for patients. Overseeing the performance of multiple locations across Pennsylvania and New Jersey, the Chief Operating Officer maintains rigorous quality control standards. This role involves coordinating with technical staff to optimize the use of laboratory equipment and diagnostic technology. Warren Erdmann monitors operational metrics to identify bottlenecks and implement process improvements that enhance service delivery. By streamlining the supply chain for testing materials, the Chief Operating Officer supports the needs of hospitals and physician offices. Erdmann ensures that all operational activities comply with regulatory requirements and internal safety protocols. Through the effective management of laboratory resources, the Chief Operating Officer drives the efficiency and reliability that define the organization's reputation in the medical diagnostics industry.

Jessica Bargilione, the Chief Marketing Officer at HNL Lab Medicine, directs all brand positioning and market outreach strategies. Bargilione architects campaigns that highlight the comprehensive diagnostic capabilities of the laboratory to hospitals and physician offices. By analyzing regional market data, the Chief Marketing Officer identifies opportunities for growth within Pennsylvania and New Jersey. This role involves managing the public perception of the organization and ensuring that the value proposition reaches key healthcare stakeholders. Jessica Bargilione coordinates with clinical leadership to translate complex pathology services into clear, actionable information for clients. Through targeted outreach, the Chief Marketing Officer drives engagement with industrial clients and long-term care facilities. Bargilione monitors the effectiveness of communication channels to ensure consistent brand messaging. By aligning marketing efforts with the broader business goals, the Chief Marketing Officer supports the expansion of the laboratory's footprint and reinforces the commitment to high-quality diagnostic services.

Angela Connell, the Chief Administrative Officer at HNL Lab Medicine, directs the internal infrastructure and organizational support systems. Connell architects policies that streamline human resources, facility management, and administrative workflows. By overseeing the operational environment, the Chief Administrative Officer ensures that clinical teams have the necessary support to deliver high-quality diagnostic services. This role involves managing organizational compliance and internal governance to maintain the integrity of laboratory operations. Angela Connell coordinates with department heads to improve cross-functional communication and efficiency. Through the implementation of administrative best practices, the Chief Administrative Officer supports the growth of the organization across Pennsylvania and New Jersey. Connell monitors the effectiveness of internal systems to ensure they meet the demands of a full-service medical laboratory. By fostering a productive work environment, the Chief Administrative Officer enables the staff to focus on providing exceptional pathology results to healthcare providers and patients.